Russell P. Pagano insider trades: Biomimetic Therapeutics (BMTI) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Russell reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 22, 2013 | BMTI | ↓ Sell | 1,381 | $8.10 | $11K | Direct | Jan 24, 2013 (2d) |
| Mar 29, 2012 | BMTI | ↓ Sell | 3,438 | $2.36 | $8K | Direct | Apr 16, 2012 (18d) |
| May 19, 2011 | BMTI | ↑ Buy | 1,900 | $7.95 | $15K | Direct | May 20, 2011 (1d) |
| Jan 25, 2011 | BMTI | ↓ Sell | 771 | $13.32 | $10K | Direct | Jan 26, 2011 (1d) |
| Oct 18, 2010 | BMTI | ↓ Sell | 1,829 | $12.20 | $22K | Direct | Oct 20, 2010 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Russell P. Pagano's insider trades
Russell P. Pagano is VP, Reg. & Clinical Affairs at Biomimetic Therapeutics (BMTI). Since Oct 18, 2010, Russell has reported 1 open-market purchase worth $15K and 4 sales worth $52K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (6 filings), shares returned to the company (1 filing), shares withheld for taxes (1 filing), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BMTI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.